David A. Esposito
Chief Executive Officer at Armune BioScience, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Fred Turner | M | - |
Shield Diagnostics Corp.
Shield Diagnostics Corp. Packaged SoftwareTechnology Services Shield Diagnostics Corp. develops advanced genotyping technologies for high throughput and high density testing. It offers beef and dairy cattle. The company was founded by Fred Turner and Sam Parlett and is headquartered in Santa Clara, CA. | 8 years |
David Zacks | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | 13 years |
Susan J. Crookston | F | - |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 10 years |
Sam Parlett | M | - |
Shield Diagnostics Corp.
Shield Diagnostics Corp. Packaged SoftwareTechnology Services Shield Diagnostics Corp. develops advanced genotyping technologies for high throughput and high density testing. It offers beef and dairy cattle. The company was founded by Fred Turner and Sam Parlett and is headquartered in Santa Clara, CA. | - |
Tom Glocer | M | 63 | 17 years | |
Vincent C. Caponi | M | 73 | 10 years | |
Stephen Meyer | M | 65 | 7 years | |
Jim Garner | M | - |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
Donald Parfet | M | 71 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
Peter Wendell | M | 73 | 21 years | |
Russ Fein | M | - |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
C. Harris | M | 67 | 12 years | |
James S. Arthurs | M | - |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
Cynthia L. Grosskreutz | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Connie Chang | F | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | 3 years |
William R. Burns | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Mark E. Hooper | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Pamela Eisele | F | - | 15 years | |
Vijay Aggarwal | M | - |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
James Matteucci | M | - | 21 years | |
Stella M. Robertson | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Stephanie Lynn Sorensen | F | 54 | 8 years | |
Marian Nakada | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Dennis P. Kane | M | 71 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
James Sollins | M | - |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
John C. Simons | M | - |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
Hugh A. Sampson | M | 75 |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
Ronald Weiss | M | - |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | - |
Gil Omenn | M | 83 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 16 years |
Vijay Aggarwal | M | 75 |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | - |
Steven Graziano | M | - | 18 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 years | |
Richard Kogan | M | 81 | 21 years | |
Eli L. Thomssen | M | - |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 8 years |
Philip A. Theodore | M | 70 | 1 years | |
Raymond Gilmartin | M | 82 | 2 years | |
Richard Clark | M | 77 | 6 years | |
Bobby Dwayne Montgomery | M | 56 | 6 years | |
Fred Hassan | M | 78 | 6 years | |
Rochelle Lazarus | F | 76 | 16 years | |
Michael Porter | M | 76 | 11 years | |
Kenneth Bartizal | M | 72 | 20 years | |
Craig Thompson | M | 71 | 10 years | |
Joseph Romanelli | M | 50 | 19 years | |
David Gionco | M | 63 | 3 years | |
Ismail Kola | M | 67 | 4 years | |
Richard Garret Solomon | M | 81 | 14 years | |
Jeffrey Burger | M | - |
Syracuse University
| 5 years |
Tommy Auger | M | 54 | 6 years | |
Megan Neuberger | F | - |
Syracuse University
| 5 years |
Robert Iannone | M | 57 | 6 years | |
Larry G. Edwards | M | 52 | 15 years | |
Laura Sepp-Lorenzino | M | 63 | 15 years | |
Natarajan Sethuraman | M | 62 | 10 years | |
Daniel D. Hoyt | M | 84 | 15 years | |
Jennifer Shea | F | - |
Syracuse University
| 4 years |
Edwin G. Marshall | M | 81 | 20 years | |
Lars Rebien Sørensen | M | 69 | 4 years | |
Leslie Brun | M | 72 | 13 years | |
Richard Henriques | M | 68 | 27 years | |
Wendell Weeks | M | 64 | 16 years | |
Anne Tatlock | F | 84 | - | |
David Anstice | M | 75 | 5 years | |
Steven Goldstone | M | 78 | 6 years | |
Charles Kidder | M | 79 | 12 years | |
Thomas Shenk | M | 77 | 11 years | |
David Dodd | M | 74 | 1 years | |
William Harrison | M | 80 | - | |
Wendy Yarno | F | 69 | 9 years | |
Kevin Cooper | M | - |
Syracuse University
| 3 years |
Franklin Clyburn | M | 59 | 13 years | |
Jamie Choi | M | - |
Syracuse University
| 2 years |
Heather Morice | F | - |
Syracuse University
| 4 years |
Chris Staneluis | M | - |
Syracuse University
| 3 years |
Vincent Lawton | M | 75 | - | |
James Christopher Scalet | M | 65 | 9 years | |
François Meurgey | M | - | - | |
Stephen Farrand | M | - | 6 years | |
Tassos Gianakakos | M | 51 | 2 years | |
Barbara Yanni | F | 69 | 13 years | |
Pernilla Sandwall | F | 61 | 8 years | |
Scott Philip Sobel | M | - |
Syracuse University
| 4 years |
Angelique M. Carbo | F | 59 | 2 years | |
Vijay Tammara | M | 64 | 6 years | |
Glenn Williams | M | - | 10 years | |
Kamil Ali-Jackson | F | 65 | 8 years | |
Erin McClain | F | - | - | |
Michael J. Senno | M | - |
Syracuse University
| 4 years |
Gerald J. Gallivan | M | - | - | |
Erin Luciano | F | - |
Syracuse University
| 4 years |
Ken Weinstein | M | - |
Syracuse University
| 1 years |
Gregory S. Patrick | M | 72 | 14 years | |
Thomas Martin Vernon | M | 85 | - | |
David Monteith | M | 60 | 5 years | |
Berta Strulovici | M | - | - | |
Graeme Bell | M | 57 | 2 years | |
John Z. Sullivan-Bólyai | M | 76 | 11 years | |
Paul M. Mendelman | M | 76 | 5 years | |
Franz Hefti | M | 76 | 7 years | |
F. Alec Orudjev | M | - |
Syracuse University
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David A. Esposito
- Personal Network